Literature DB >> 16634022

Polymorphisms in the vitamin D receptor and their associations with risk of schizophrenia and selected anthropometric measures.

H Y Handoko1, D J Nancarrow, B J Mowry, J J McGrath.   

Abstract

The association between vitamin D levels and skeletal growth has long been recognized. However, exposure to low levels of vitamin D during early life is also known to alter brain development, and is a candidate risk factor for schizophrenia. This study examines the association between four polymorphisms in the vitamin D receptor (VDR) and 1) risk of schizophrenia, and 2) three anthropometric variables (height, head size, and head shape). Four single-nucleotide polymorphisms (SNPs; rs10735810/FokI, rs1544410/BsmI, rs7975232/ApaI, and rs731236/TaqI) in the VDR gene were genotyped in 179 individuals with schizophrenia and 189 healthy controls. No significant associations were detected between any of the four VDR SNPs and risk of schizophrenia. Patients were slightly but significantly shorter compared to controls. Of the four SNPs, only rs10735810/FokI was associated with any of the anthropometric measures: the M4 isoform of this SNP was significantly associated with larger head size (P = 0.002). In light of the evidence demonstrating a role for vitamin D during brain development, the association between polymorphisms in VDR and brain development warrants closer scrutiny.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634022     DOI: 10.1002/ajhb.20504

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  8 in total

Review 1.  Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry.

Authors:  Anastasia K Yocum; Arul M Chinnaiyan
Journal:  Brief Funct Genomic Proteomic       Date:  2009-03-11

Review 2.  Vitamin D and the occurrence of depression: causal association or circumstantial evidence?

Authors:  Elizabeth R Bertone-Johnson
Journal:  Nutr Rev       Date:  2009-08       Impact factor: 7.110

3.  Association Study of Vitamin D Receptor (VDR) - Related Genetic Polymorphisms and their Haplotypes with Chronic Periodontitis in Colombian Population.

Authors:  Sergio Iván Tobón-Arroyave; Diana María Isaza-Guzmán; Nicolás Pineda-Trujillo
Journal:  J Clin Diagn Res       Date:  2017-02-01

4.  Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk.

Authors:  Sara Karami; Paul Brennan; Philip S Rosenberg; Marie Navratilova; Dana Mates; David Zaridze; Vladimir Janout; Helena Kollarova; Vladimir Bencko; Vsevolod Matveev; Neonila Szeszenia-Dabrowska; Ivana Holcatova; Meredith Yeager; Stephen Chanock; Idan Menashe; Nathaniel Rothman; Wong-Ho Chow; Paolo Boffetta; Lee E Moore
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

5.  Nuclear Receptors and Neuroinflammation in Schizophrenia.

Authors:  Shan-Yuan Tsai; Vibeke S Catts; Janice M Fullerton; Susan M Corley; Stuart G Fillman; Cynthia Shannon Weickert
Journal:  Mol Neuropsychiatry       Date:  2018-01-16

6.  Computational selection and prioritization of candidate genes for fetal alcohol syndrome.

Authors:  Zané Lombard; Nicki Tiffin; Oliver Hofmann; Vladimir B Bajic; Winston Hide; Michèle Ramsay
Journal:  BMC Genomics       Date:  2007-10-25       Impact factor: 3.969

7.  Association between Fok I vitamin D receptor gene (VDR) polymorphism and impulsivity in alcohol-dependent patients.

Authors:  Małgorzata Wrzosek; Andrzej Jakubczyk; Michał Wrzosek; Beata Kaleta; Jacek Łukaszkiewicz; Halina Matsumoto; Kirk Brower; Grażyna Nowicka; Marcin Wojnar
Journal:  Mol Biol Rep       Date:  2014-07-25       Impact factor: 2.316

8.  Vitamin D levels, brain volume, and genetic architecture in patients with psychosis.

Authors:  Akiah Ottesen Berg; Kjetil N Jørgensen; Mari Nerhus; Lavinia Athanasiu; Alice B Popejoy; Francesco Bettella; Linn Christin Bonaventure Norbom; Tiril P Gurholt; Sandra R Dahl; Ole A Andreassen; Srdjan Djurovic; Ingrid Agartz; Ingrid Melle
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.